T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.35% |
| 2 | Healthcare | 16.19% |
| 3 | Consumer Discretionary | 15.55% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Health Catalyst
HCAT
$132M
| $659K | ﹤0.01% |
14,083
+13
| +0.1% | +$630 |
|
|
ACRE
2227
Ares Commercial Real Estate
ACRE
$264M
| $657K | ﹤0.01% |
47,855
-15
| -0% | -$196 |
|
2228
Brookfield Renewable
BEPC
$6.66B
| $655K | ﹤0.01% |
14,003
+3,649
| +35% | +$186K |
|
|
MRNS
2229
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $653K | ﹤0.01% |
+42,186
| New | +$610K |
|
2230
Hamilton Lane
HLNE
$5.91B
| $652K | ﹤0.01% |
7,366
-95,584
| -93% | -$8.08M |
|
|
MIC
2231
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $652K | ﹤0.01% |
20,510
+4,187
| +26% | +$131K |
|
2232
LendingTree
TREE
$461M
| $651K | ﹤0.01% |
3,055
+70
| +2% | +$19.9K |
|
2233
iShares Core Dividend Growth ETF
DGRO
$43.9B
| $649K | ﹤0.01% |
13,439
| – | – |
|
2234
1st Source
SRCE
$2.13B
| $647K | ﹤0.01% |
13,607
+10
| +0.1% | +$445 |
|
2235
Boise Cascade
BCC
$2.94B
| $642K | ﹤0.01% |
10,732
-1,106
| -9% | -$58.4K |
|
2236
Celsius Holdings
CELH
$7.28B
| $642K | ﹤0.01% |
40,062
+20,331
| +103% | +$382K |
|
2237
G-III Apparel Group
GIII
$1.43B
| $638K | ﹤0.01% |
21,164
-6,463
| -23% | -$188K |
|
2238
AMC Global Media
AMCX
$496M
| $636K | ﹤0.01% |
11,955
-1,686,472
| -99% | -$92.2M |
|
|
UMH
2239
UMH Properties
UMH
$1.42B
| $636K | ﹤0.01% |
33,199
-40
| -0.1% | -$674 |
|
2240
Community Trust Bancorp
CTBI
$1.44B
| $634K | ﹤0.01% |
14,407
+1,003
| +7% | +$41.2K |
|
2241
Mastech Digital
MHH
$95.3M
| $634K | ﹤0.01% |
35,988
+25
| +0.1% | +$427 |
|
2242
Materion
MTRN
$5.88B
| $634K | ﹤0.01% |
9,567
-797
| -8% | -$55.3K |
|
2243
Cytokinetics
CYTK
$10.2B
| $632K | ﹤0.01% |
27,180
+3,654
| +16% | +$78K |
|
|
EGOV
2244
DELISTED
NIC Inc
EGOV
| $630K | ﹤0.01% |
18,579
+21
| +0.1% | +$663 |
|
2245
MBIA
MBI
$262M
| $628K | ﹤0.01% |
65,247
-14
| -0% | -$108 |
|
2246
Progyny
PGNY
$1.99B
| $628K | ﹤0.01% |
14,115
-11,861
| -46% | -$554K |
|
|
EGRX
2247
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $628K | ﹤0.01% |
15,039
-4,801
| -24% | -$223K |
|
2248
Hackett Group
HCKT
$277M
| $627K | ﹤0.01% |
38,238
-26
| -0.1% | -$402 |
|
|
KBAL
2249
DELISTED
Kimball International
KBAL
| $626K | ﹤0.01% |
44,685
+4,098
| +10% | +$53.2K |
|
2250
Agilysys
AGYS
$3.25B
| $625K | ﹤0.01% |
13,027
-4,033
| -24% | -$201K |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.